<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>p53 has been implicated as a determinant of chemosensitivity and radiosensitivity </plain></SENT>
<SENT sid="1" pm="."><plain>We measured chemosensitivity of human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell lines (n = 11), with or without <z:mp ids='MP_0002169'>wild-type</z:mp> p53, following exposure to clinically useful chemotherapeutic drugs (n = 4) </plain></SENT>
<SENT sid="2" pm="."><plain>Chemosensitivity and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induction were correlated independently of p53 status or Bcl-2 protein levels in vitro </plain></SENT>
<SENT sid="3" pm="."><plain><z:mp ids='MP_0002169'>Wild-type</z:mp> p53 correlated with chemosensitivity in <z:mp ids='MP_0003579'>ovarian carcinoma</z:mp> and some Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells, but not in <z:hpo ids='HP_0001909'>leukemia</z:hpo> or <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Bcl-2 levels correlated with chemoresistance only in Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>p53-dependent p21(WAF1/CIP1) induction and cell cycle arrest occurred at sublethal doses of chemotherapy, whereas at lethal doses of chemotherapy apoptotic <z:hpo ids='HP_0011420'>death</z:hpo> was observed, consistent with models proposing a relationship between the level of DNA damage versus survival or <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Loss of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induction was observed in drug-resistant ML-1 and <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells, without changes in p53 or Bcl-2 </plain></SENT>
<SENT sid="7" pm="."><plain>Targeted loss of p53 protein in H460 <z:e sem="disease" ids="C0242379" disease_type="Neoplastic Process" abbrv="">lung cancer</z:e> cells using HPV-16 E6 inhibited the <z:chebi fb="0" ids="4911">etoposide</z:chebi>-induced G1 checkpoint but did not decrease chemosensitivity </plain></SENT>
<SENT sid="8" pm="."><plain>Our studies suggest that the simple measurement of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> induction may be a useful predictor of chemosensitivity, at least in vitro, and confirm that p53 status and Bcl-2 expression may be useful predictors of chemosensitivity in certain cell types </plain></SENT>
</text></document>